Claims for GLP-1s Increased Four-Fold Between 2019 and 2024 In accordance with an increase in both the number of Medicare Part D enrollees using GLP-1s and spending on these products, the number of claims for GLP-1s increased four-fold between 2019 and 2024, from 4.8 million to 21.8 million, with claims doubling between 2022 and 2024 alone
Summary References Xie, Y., Choi, T., & Al-Aly, Z
Maybe, the most efficient way to influence the composition of intestinal and colon microbiota is by ingestion of dietary fibers such as inulin-type fructans, xylooligosaccharides, arabinoxylans, arabinoxylan oligosaccharides, -glucans, and oligofructose (2528)
This distinction matters because it indicates the issue stems from altered motility and fluid absorption rather than any damage to intestinal tissue
Some suppliers allow stacking and others do not
In high amounts, it's pro-oxidative